BALYASNY ASSET MANAGEMENT L.P. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$119,380,000
+62077.1%
1,403,965
+9741.3%
0.88%
+43650.0%
Q1 2020$192,000
-90.9%
14,266
-85.7%
0.00%
-84.6%
Q4 2019$2,116,000
+1190.2%
100,000
+768.1%
0.01%
+1200.0%
Q4 2018$164,000
-98.2%
11,520
-97.0%
0.00%
-97.6%
Q2 2018$9,236,000
+180.3%
390,185
+65.6%
0.04%
+223.1%
Q3 2017$3,295,000
-35.4%
235,687
-85.0%
0.01%
-55.2%
Q3 2016$5,102,000
+100.7%
1,569,885
+43.3%
0.03%
+81.2%
Q2 2016$2,542,000
-54.4%
1,095,676
-50.9%
0.02%
-51.5%
Q1 2016$5,576,000
-49.2%
2,230,112
-37.7%
0.03%
-56.6%
Q4 2015$10,983,000
+141.5%
3,577,594
+35.3%
0.08%
+130.3%
Q3 2015$4,548,000
+273.4%
2,644,478
+781.5%
0.03%
+371.4%
Q2 2015$1,218,000300,0000.01%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders